Based on the result of univariate and multivariate analysis, PSMD2 has been identified as an independent prognostic biomarker for overall survival in bladder urothelial carcinoma (Salah Fararjeh et al., 2021). Here, PSMD2 is linked to bladder transitional cell carcinoma.